Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Royalty revenue | | | | | | | | 8.3 |
| Product sales | | | | | | | | 13.0 |
| Other | | | | | | | | 45.0 |
| Total revenues [+] | 316.6 | 171.5 | 187.8 | 195.9 | 213.3 | 236.7 | 189.5 | 66.2 |
| Royalties | | | | | | | | 8.3 |
| Products | | | | | | | | 13.0 |
| Other | | | | | | | | 45.0 |
| Revenue growth | 84.6% | -8.7% | -4.1% | -8.2% | -9.9% | 24.9% | 186.1% | |
| Cost of goods sold | 85.5 | 31.5 | 33.6 | 47.9 | 42.4 | 33.7 | 35.8 | 7.8 |
| Gross profit | 231.2 | 140.0 | 154.2 | 148.0 | 170.9 | 203.0 | 153.7 | 58.5 |
| Gross margin | 73.0% | 81.6% | 82.1% | 75.6% | 80.1% | 85.8% | 81.1% | 88.3% |
| Selling, general and administrative | 106.6 | 75.3 | 78.6 | 76.4 | 60.5 | 71.4 | 53.3 | 20.2 |
| Research and development | 34.1 | 51.3 | 30.8 | 36.8 | 44.4 | 32.6 | 28.3 | 27.9 |
| Other operating expenses | 9.5 | 10.7 | 11.8 | 13.0 | 19.5 | 23.5 | 19.5 | 7.9 |
| EBITDA [+] | 93.0 | 6.5 | 36.5 | 25.3 | 50.1 | 79.2 | 54.1 | 2.7 |
| EBITDA growth | 1324.2% | -82.1% | 44.2% | -49.5% | -36.7% | 46.4% | 1926.5% | |
| EBITDA margin | 29.4% | 3.8% | 19.4% | 12.9% | 23.5% | 33.5% | 28.6% | 4.0% |
| Depreciation | 0.6 | 0.8 | 0.9 | 1.0 | 1.2 | 0.9 | 0.6 | 0.1 |
| EBITA | 92.3 | 5.8 | 35.6 | 24.3 | 49.0 | 78.3 | 53.5 | 2.6 |
| EBITA margin | 29.2% | 3.4% | 19.0% | 12.4% | 23.0% | 33.1% | 28.2% | 3.9% |
| Amortization of intangibles | 11.4 | 3.0 | 2.7 | 2.5 | 2.5 | 2.8 | 0.9 | |
| EBIT [+] | 81.0 | 2.8 | 33.0 | 21.8 | 46.5 | 75.5 | 52.6 | 2.6 |
| EBIT growth | 2823.8% | -91.6% | 51.1% | -53.1% | -38.5% | 43.6% | 1953.0% | |
| EBIT margin | 25.6% | 1.6% | 17.5% | 11.1% | 21.8% | 31.9% | 27.7% | 3.9% |
| Non-recurring items [+] | | | | | 9.9 | 1.5 | -0.8 | |
| Asset impairment | | | | | 2.7 | 7.2 | | |
| Loss (gain) on sale of assets | | | | | | | -1.8 | |
| Legal settlement | | | | | | 1.7 | | |
| Loss on contingent liability | | | | | -0.8 | -7.4 | 1.0 | |
| Interest expense, net [+] | 3.8 | 1.1 | 2.0 | 0.5 | 2.6 | 1.0 | -0.1 | 0.0 |
| Interest expense | 4.0 | 1.6 | 2.6 | 2.7 | 2.7 | 1.1 | 0.0 | 0.0 |
| Interest income | 0.3 | 0.6 | 0.6 | 2.2 | 0.2 | 0.1 | 0.1 | 0.0 |
| Other income (expense), net [+] | -15.8 | -6.2 | -8.3 | 0.7 | | | | |
| Other | -15.8 | -6.2 | -8.3 | 0.7 | | | | |
| Pre-tax income | 61.4 | -4.5 | 22.7 | 22.0 | 34.0 | 72.9 | 53.4 | 2.6 |
| Income taxes | 25.8 | 4.1 | 10.7 | 7.7 | 2.1 | 21.0 | -28.0 | 0.0 |
| Tax rate | 42.0% | | 47.1% | 34.9% | 6.3% | 28.8% | | 0.1% |
| Net income | 35.6 | -8.6 | 12.0 | 14.3 | 31.9 | 51.9 | 81.5 | 2.6 |
| Net margin | 11.3% | -5.0% | 6.4% | 7.3% | 15.0% | 21.9% | 43.0% | 3.9% |
| |
| Basic EPS [+] | $2.76 | ($0.66) | $0.89 | $1.04 | $2.16 | $3.44 | $5.24 | $0.17 |
| Growth | -516.9% | -174.3% | -14.5% | -51.8% | -37.2% | -34.4% | 3010.3% | |
| Diluted EPS [+] | $2.73 | ($0.66) | $0.87 | $1.01 | $2.09 | $3.27 | $4.96 | $0.16 |
| Growth | -512.7% | -175.9% | -14.0% | -51.5% | -36.0% | -34.1% | 3033.4% | |
| |
| |
| Shares outstanding (basic) [+] | 12.9 | 13.1 | 13.5 | 13.8 | 14.8 | 15.1 | 15.5 | 15.3 |
| Growth | -0.9% | -3.2% | -2.0% | -6.9% | -2.2% | -2.8% | 1.9% | |
| Shares outstanding (diluted) [+] | 13.1 | 13.1 | 13.8 | 14.1 | 15.3 | 15.9 | 16.4 | 16.3 |
| Growth | 0.1% | -5.2% | -2.6% | -7.5% | -4.0% | -3.2% | 1.1% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|